(Reuters) - Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets ...
Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...
Investors, shrugging off ongoing concerns around trade and inflation, are searching for the next catalyst to send stocks ...
These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Shares of Roku Inc (NASDAQ:ROKU) are up 14.5% in premarket trading, after the streaming giant shared smaller-than-expected ...
The Hang Seng Tech Index jumped 5.6% to a three-year high at close, bringing the week's advance to 7.3% and recording a fifth ...
U.S. stock futures were little changed on Thursday night after President Donald Trump held off on imposing new reciprocal ...